CVS HEALTH CORPORATION (CVS) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 11.33B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $11.33B | (m) | (m) |
| 2026-03-31 | (m) | (m) | $9.54B | (m) | (m) |
| 2025-12-31 | (m) | (m) | $8.45B | (m) | (m) |
| 2025-09-30 | (m) | (m) | $9.10B | (m) | (m) |
| 2025-06-30 | (m) | (m) | $11.79B | (m) | (m) |
| 2025-03-31 | (m) | (m) | $10.08B | (m) | (m) |
| 2024-12-31 | (m) | (m) | $8.59B | (m) | (m) |
| 2024-09-30 | (m) | (m) | $6.88B | (m) | (m) |
| 2024-06-30 | (m) | (m) | $12.51B | (m) | (m) |
| 2024-03-31 | (m) | (m) | $9.80B | (m) | (m) |
| 2023-12-31 | (m) | (m) | $8.20B | (m) | (m) |
| 2023-09-30 | (m) | (m) | $13.04B | (m) | (m) |
| 2023-06-30 | (m) | (m) | $13.81B | (m) | (m) |
| 2023-03-31 | (m) | (m) | $14.62B | (m) | (m) |
| 2022-12-31 | (m) | (m) | $12.95B | (m) | (m) |
| 2022-09-30 | (m) | (m) | $17.20B | (m) | (m) |
| 2022-06-30 | (m) | (m) | $12.12B | (m) | (m) |
| 2022-03-31 | (m) | (m) | $8.44B | (m) | (m) |
| 2021-12-31 | (m) | (m) | $9.41B | (m) | (m) |
| 2021-09-30 | (m) | (m) | $9.83B | (m) | (m) |
| 2021-06-30 | (m) | (m) | $7.12B | (m) | (m) |
| 2021-03-31 | (m) | (m) | $5.60B | (m) | (m) |
| 2020-12-31 | (m) | (m) | $7.85B | (m) | (m) |
| 2020-09-30 | (m) | (m) | $9.26B | (m) | (m) |
| 2020-06-30 | (m) | (m) | $14.87B | (m) | (m) |
| 2020-03-31 | (m) | (m) | $10.08B | (m) | (m) |
| 2019-12-31 | (m) | (m) | $5.68B | (m) | (m) |
| 2019-09-30 | (m) | (m) | $5.19B | (m) | (m) |
| 2019-06-30 | (m) | (m) | $6.06B | (m) | (m) |
| 2019-03-31 | (m) | (m) | $5.90B | (m) | (m) |
| 2018-12-31 | $6.42B | (m) | $4.06B | $2.36B | (m) |
| 2018-09-30 | (m) | (m) | $41.59B | (m) | (m) |
| 2018-06-30 | (m) | (m) | $43.81B | (m) | (m) |
| 2018-03-31 | (m) | (m) | $42.02B | (m) | (m) |
| 2017-12-31 | (m) | (m) | $1.70B | (m) | (m) |
| 2017-09-30 | (m) | (m) | $2.48B | (m) | (m) |
| 2017-06-30 | (m) | (m) | $2.09B | (m) | (m) |
| 2017-03-31 | (m) | (m) | $2.22B | (m) | (m) |
| 2016-12-31 | (m) | (m) | $3.37B | (m) | (m) |
| 2016-09-30 | (m) | (m) | $2.19B | (m) | (m) |
| 2016-06-30 | (m) | (m) | $1.13B | (m) | (m) |
| 2016-03-31 | (m) | (m) | $1.78B | (m) | (m) |
| 2015-12-31 | (m) | (m) | $2.46B | (m) | (m) |
| 2015-09-30 | (m) | (m) | $2.89B | (m) | (m) |
| 2015-06-30 | (m) | (m) | $1.24B | (m) | (m) |
| 2015-03-31 | (m) | (m) | $1.52B | (m) | (m) |
| 2014-12-31 | (m) | (m) | $2.48B | (m) | (m) |
| 2014-09-30 | (m) | (m) | $1.13B | (m) | (m) |
| 2014-06-30 | (m) | (m) | $1.61B | (m) | (m) |
| 2014-03-31 | (m) | (m) | $2.77B | (m) | (m) |
| 2013-12-31 | (m) | (m) | $4.09B | (m) | (m) |
| 2013-09-30 | (m) | (m) | $1.50B | (m) | (m) |
| 2013-06-30 | (m) | (m) | $1.17B | (m) | (m) |
| 2013-03-31 | (m) | (m) | $1.55B | (m) | (m) |
| 2012-12-31 | (m) | (m) | $1.38B | (m) | (m) |
| 2012-09-30 | (m) | (m) | $1.23B | (m) | (m) |
| 2012-06-30 | (m) | (m) | $1.82B | (m) | (m) |
| 2012-03-31 | (m) | (m) | $2.21B | (m) | (m) |
| 2011-12-31 | (m) | (m) | $1.41B | (m) | (m) |
| 2011-09-30 | (m) | (m) | $1.71B | (m) | (m) |
| 2011-06-30 | (m) | (m) | $2.23B | (m) | (m) |
| 2011-03-31 | (m) | (m) | $2.16B | (m) | (m) |
| 2010-12-31 | (m) | (m) | $1.43B | (m) | (m) |
| 2010-09-30 | (m) | (m) | $979.00M | (m) | (m) |
| 2010-06-30 | (m) | (m) | $1.11B | (m) | (m) |
| 2010-03-31 | (m) | (m) | $1.05B | (m) | (m) |
| 2009-12-31 | (m) | (m) | $1.09B | (m) | (m) |
| 2009-09-30 | (m) | (m) | $1.13B | (m) | (m) |
| 2009-06-30 | (m) | (m) | $1.23B | (m) | (m) |
| 2009-03-31 | (m) | (m) | $997.00M | (m) | (m) |
| 2008-12-31 | (m) | (m) | $1.35B | (m) | (m) |
| 2008-09-27 | (m) | (m) | $1.28B | (m) | (m) |
| 2008-06-28 | (m) | (m) | $615.70M | (m) | (m) |
| 2007-12-29 | (m) | (m) | $1.06B | (m) | (m) |
| 2006-12-30 | (m) | (m) | $530.00M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |